Delivery Order SPE2DB22D2009-SPE2DB25FL9TW
Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $35,464.57 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Rexulti 0.5 mg tablets in quantities of 30. This firm fixed price delivery order, with an ultimate completion date of July 25, 2025, represents a pharmaceutical supply transaction supporting federal medical procurement needs. The award was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $10,036.57 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its Conshohocken facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,026.20 to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Rexulti 3 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by June 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $17,977.69 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (quantity: 30 count) under a firm fixed price contract. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a non-set-aside competitive award, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) on August 13, 2025, with a ceiling value of $1,002.23 and firm fixed pricing. This delivery order is non-set-aside and represents a competitive award to the pharmaceutical distributor, with an ultimate completion date of August 14, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,927.61 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Rexulti 2 mg tablets (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $9,608.75 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count packaging) on April 23, 2025, with completion scheduled for April 24, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical transaction under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order valued at $8,429.48 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count) under a firm fixed price contract type. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and reflects a non-competitive set-aside approach. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania, serving the federal medical supply chain...
- The Defense Logistics Agency awarded a $41,480.93 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Rexulti 1 mg tablets (30-count units). This firm fixed-price, competitively awarded contract with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $14,851.46 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets in a 30-count package. This firm fixed price, competitively awarded contract was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this delivery order represents a routine pharmaceutical supply...